Bristol-Myers Squibb (BMY)
61.12
1.10 (1.83%)
At close: Mar 31, 2025, 3:59 PM
60.87
-0.40%
After-hours: Mar 31, 2025, 07:46 PM EDT
Breyanzi Revenue
History
| Quarter | Value | Change | Growth |
|---|---|---|---|
| Jun 30, 2023 | 100M | 29M | +40.85% |
| Mar 31, 2023 | 71M | 16M | +29.09% |
| Dec 31, 2022 | 55M | 11M | +25.00% |
| Sep 30, 2022 | 44M | 5M | +12.82% |
| Jun 30, 2022 | 39M | -5M | -11.36% |
| Mar 31, 2022 | 44M | 4M | +10.00% |
| Dec 31, 2021 | 40M | 10M | +33.33% |
| Sep 30, 2021 | 30M | 13M | +76.47% |
| Jun 30, 2021 | 17M | 1M | +6.25% |
| Mar 31, 2021 | 16M | 1M | +6.67% |
| Dec 31, 2020 | 15M | 2M | +15.38% |
| Sep 30, 2020 | 13M | -2M | -13.33% |
| Jun 30, 2020 | 15M | 3M | +25.00% |
| Mar 31, 2020 | 12M | -780M | -98.48% |
| Dec 31, 2019 | 792M | 25M | +3.26% |
| Sep 30, 2019 | 767M | -11M | -1.41% |
| Jun 30, 2019 | 778M | 138M | +21.56% |
| Mar 31, 2019 | 640M | -91M | -12.45% |
| Dec 31, 2018 | 731M | 56M | +8.30% |
| Sep 30, 2018 | 675M | -36M | -5.06% |
| Jun 30, 2018 | 711M | 118M | +19.90% |
| Mar 31, 2018 | 593M | -69M | -10.42% |
| Dec 31, 2017 | 662M | 30M | +4.75% |
| Sep 30, 2017 | 632M | -18M | -2.77% |
| Jun 30, 2017 | 650M | 115M | +21.50% |
| Mar 31, 2017 | 535M | -90M | -14.40% |
| Dec 31, 2016 | 625M | 53M | +9.27% |
| Sep 30, 2016 | 572M | -21M | -3.54% |
| Jun 30, 2016 | 593M | 118M | +24.84% |
| Mar 31, 2016 | 475M | -65M | -12.04% |
| Dec 31, 2015 | 540M | 56M | +11.57% |
| Sep 30, 2015 | 484M | 23M | +4.99% |
| Jun 30, 2015 | 461M | 61M | +15.25% |
| Mar 31, 2015 | 400M | -43M | -9.71% |
| Dec 31, 2014 | 443M | -1M | -0.23% |
| Sep 30, 2014 | 444M | 76M | +20.65% |
| Jun 30, 2014 | 368M | 26M | +7.60% |
| Mar 31, 2014 | 342M | -310M | -47.55% |
| Dec 31, 2013 | 652M | 414M | +173.95% |
| Sep 30, 2013 | 238M | -74M | -23.72% |
| Jun 30, 2013 | 312M | n/a | n/a |